Healthcare Sector Companies to See: Tetraphase Pharmaceuticals Inc (TTPH), Baxter International Inc (BAX)

0
64

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH):

Stock’s Trading Stats:

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH surged 0.76% yesterday and closed at $5.32. The company’s market capitalization is at $218.27 Million with an average trading volume of 1.02 Million. The total number of Outstanding Shares Held by the company are 36.60 Million.

Recent Press Release:

Tetraphase Pharmaceuticals, Inc. (TTPH) on April 7, 2016 declared five data presentations at the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), taking place April 9-12 in Amsterdam, Netherlands.  Presentations will comprise information about the company’s lead drug candidate, eravacycline, in addition to data from its preclinical TP-6076 program.

Tetraphase is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening bacterial infections, counting those caused by many of the multidrug-resistant (MDR) bacteria highlighted as urgent public health threats by the CDC. Tetraphase has created more than 3,000 novel tetracycline analogs using its proprietary technology platform. Tetraphase’s pipeline comprises its late-stage broad-spectrum antibiotic, eravacycline, in addition to two additional antibiotic candidates, TP-271 and TP-6076. Please visit www.tphase.com for more company information.

Baxter International Inc (NYSE:BAX):

Stock’s Trading Stats:

Baxter International Inc (NYSE:BAX) closed at $42.65 yesterday by showing an increase of 0.73%. The total number of outstanding shares held by the company are 550.17 Million with the total market capitalization of $23.64 billion. The number of shares traded on the last trading session are 3.52 Million.

Recent Press Release:

Baxter International Inc. (BAX) on April 5, 2016 declared that it will host an investor conference on Monday, May 9, 2016 in New York City at the Pierre Hotel. The investor conference will feature an innovation hall displaying product and therapy advancements from Baxter’s pipeline startning at 11:00 a.m. EDT. Presentations by members of the Baxter administration team will commence at 1:00 p.m. EDT.

To register for the conference, please visit www.baxter.com. Additional details are accessible on the company’s website.

The meeting and accompanying slides will be webcast live by Nasdaq OMX and will be accessible from Baxter’s corporate website at www.baxter.com. The meeting will be recorded by Baxter as copyrighted material and cannot be recorded or rebroadcast without Baxter’s permission.

Baxter provides a broad portfolio of essential renal and hospital products, counting home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.